In 2023, Reed Smith served as legal counsel to private equity funds and their portfolio companies as both acquirer and acquisition target in several notable transactions across numerous healthcare sub-sector areas including digital health, physician practices, primary care, specialty pharmacy, radiology, medical device. This reflects Reed Smith’s ability to represent clients investing in the full spectrum of the healthcare and life sciences businesses.

Reed Smith’s private equity and healthcare practices are at the forefront of developing innovative partnerships, structures, and transactions that align with the future of the health care industry and help the firm’s clients achieve their strategic and financial goals.

“Our broad and diverse day-to-day representation of health care companies gives us an edge in health care transactions; we offer unrivaled industry experience across the sector,” said Scot Hasselman, global co-chair of Reed Smith’s Life Sciences Health Industry Group.

“Our performance in this year’s PitchBook’s 2023 Annual Global League Tables is evidence that our strategy of bringing together market-leading private equity and subject-matter healthcare teams to assist our private equity clients and their portfolio companies with their most strategic transactions around the world has resonated strongly within the market,” said Chris Sheaffer, global vice-chair of Reed Smith’s Private Equity Group. “Given the cautious optimism in the market that 2024 will bring with it an increase in deal volume and deal value in healthcare private equity, our practice is well positioned to work alongside our clients as they uncover opportunities for investment in the sector.”